Pettaway CA - Search Results

1

Androgen receptor polymorphisms and risk of biochemical failure among prostatectomy patients.

Strom SS, Gu Y, Zhang H, Troncoso P, Babaian RJ, Pettaway CA, Shete S, Spitz MR, Logothetis CJ. Strom SS, et al. Among authors: pettaway ca. Prostate. 2004 Sep 1;60(4):343-51. doi: 10.1002/pros.20060. Prostate. 2004. PMID: 15264247

2

The efficacy and complications of salvage cryotherapy of the prostate.

Pisters LL, von Eschenbach AC, Scott SM, Swanson DA, Dinney CP, Pettaway CA, Babaian RJ. Pisters LL, et al. Among authors: pettaway ca. J Urol. 1997 Mar;157(3):921-5. J Urol. 1997. PMID: 9072600 Clinical Trial.

3

Prostate specific antigen and pathological features of prostate cancer in black and white patients: a comparative study based on radical prostatectomy specimens.

Pettaway CA, Troncoso P, Ramirez EI, Johnston DA, Steelhammer L, Babaian RJ. Pettaway CA, et al. J Urol. 1998 Aug;160(2):437-42. J Urol. 1998. PMID: 9679893

4

Prostate cancer in African-American men: outcome following radiation therapy with or without adjuvant androgen ablation.

Zagars GK, Pollack A, Pettaway CA. Zagars GK, et al. Among authors: pettaway ca. Int J Radiat Oncol Biol Phys. 1998 Oct 1;42(3):517-23. doi: 10.1016/s0360-3016(98)00260-0. Int J Radiat Oncol Biol Phys. 1998. PMID: 9806509

5

A feasibility study of cryotherapy followed by radical prostatectomy for locally advanced prostate cancer.

Pisters LL, Dinney CP, Pettaway CA, Scott SM, Babaian RJ, von Eschenbach AC, Troncoso P. Pisters LL, et al. Among authors: pettaway ca. J Urol. 1999 Feb;161(2):509-14. J Urol. 1999. PMID: 9915437 Clinical Trial.

6

Racial differences in the androgen/androgen receptor pathway in prostate cancer.

Pettaway CA. Pettaway CA. J Natl Med Assoc. 1999 Dec;91(12):653-60. J Natl Med Assoc. 1999. PMID: 10628124 Free PMC article. Review.

7

Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results.

Pettaway CA, Pisters LL, Troncoso P, Slaton J, Finn L, Kamoi K, Logothetis CJ. Pettaway CA, et al. J Clin Oncol. 2000 Mar;18(5):1050-7. doi: 10.1200/JCO.2000.18.5.1050. J Clin Oncol. 2000. PMID: 10694556 Clinical Trial.

8

Relative expression of type IV collagenase, E-cadherin, and vascular endothelial growth factor/vascular permeability factor in prostatectomy specimens distinguishes organ-confined from pathologically advanced prostate cancers.

Kuniyasu H, Troncoso P, Johnston D, Bucana CD, Tahara E, Fidler IJ, Pettaway CA. Kuniyasu H, et al. Among authors: pettaway ca. Clin Cancer Res. 2000 Jun;6(6):2295-308. Clin Cancer Res. 2000. PMID: 10873080

9

Interferon-alpha prevents selection of doxorubicin-resistant undifferentiated-androgen-insensitive metastatic human prostate cancer cells.

Kuniyasu H, Yasui W, Pettaway CA, Yano S, Oue N, Tahara E, Fidler IJ. Kuniyasu H, et al. Among authors: pettaway ca. Prostate. 2001 Sep 15;49(1):19-29. doi: 10.1002/pros.1114. Prostate. 2001. PMID: 11550207

10

Prostate carcinoma with testicular or penile metastases. Clinical, pathologic, and immunohistochemical features.

Tu SM, Reyes A, Maa A, Bhowmick D, Pisters LL, Pettaway CA, Lin SH, Troncoso P, Logothetis CJ. Tu SM, et al. Among authors: pettaway ca. Cancer. 2002 May 15;94(10):2610-7. doi: 10.1002/cncr.10546. Cancer. 2002. PMID: 12173328 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters